U.S. scientists who screened the blood of 1,800 HIV patients identified two antibodies -- PG9 and PG16 -- that could counteract the AIDS virus by attacking a portion that HIV uses in infecting cells. They believe the findings could lead to a better way of developing an effective vaccine against AIDS.

Full Story:

Related Summaries